Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (40)
Manoj Kumar Pandey. (2022) The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Mahmoud Mostafa, Nehal E. Elsadek, Sherif E. Emam, Hidenori Ando, Taro Shimizu, Hamdy Abdelkader, Yu Ishima, Usama Farghaly Aly, Hatem A. Sarhan & Tatsuhiro Ishida. (2022) Using Bio-Layer Interferometry to Evaluate Anti-PEG Antibody-Mediated Complement Activation. Biological and Pharmaceutical Bulletin 45:1, pages 129-135.
Crossref
Crossref
Anne Stuendl, Tanja Kraus, Madhurima Chatterjee, Björn Zapke, Boguslawa Sadowski, Wiebke Moebius, Markus A. Hobert, Christian Deuschle, Kathrin Brockmann, Walter Maetzler, Brit Mollenhauer & Anja Schneider. (2021)
α‐Synuclein
in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
. Movement Disorders 36:11, pages 2508-2518.
Crossref
Crossref
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, Wolfgang Hoyer & Henrike Heise. (2021) Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids. Chemical Reviews 121:13, pages 8285-8307.
Crossref
Crossref
Akhlaq A. Farooqui. 2018. Ischemic and Traumatic Brain and Spinal Cord Injuries. Ischemic and Traumatic Brain and Spinal Cord Injuries
1
40
.
Nor A. Samat, Nor A. Abdul Murad, Khairiyah Mohamad, Mohd R. Abdul Razak & Norlinah Mohamed Ibrahim. (2017) Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment. Frontiers in Neuroscience 11.
Crossref
Crossref
Brit Mollenhauer, Richard Batrla, Omar El-Agnaf, Douglas R. Galasko, Hilal A. Lashuel, Kalpana M. Merchant, Lesley M. Shaw, Dennis J. Selkoe, Robert Umek, Hugo Vanderstichele, Henrik Zetterberg, Jing Zhang, Chelsea Caspell-Garcia, Chris Coffey, Samantha J. Hutten, Mark Frasier & Peggy Taylor. (2017) A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations. Movement Disorders 32:8, pages 1117-1130.
Crossref
Crossref
Shieh-Yueh Yang, Ming-Jang Chiu, Chin-Hsien Lin, Herng-Er Horng, Che-Chuan Yang, Jen-Jie Chieh, Hsin-Hsien Chen & Bing-Hsien Liu. (2016) Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles. Journal of Nanobiotechnology 14:1.
Crossref
Crossref
Martín Carballo-Pacheco & Birgit Strodel. (2016) Advances in the Simulation of Protein Aggregation at the Atomistic Scale. The Journal of Physical Chemistry B 120:12, pages 2991-2999.
Crossref
Crossref
Corinna Bliederhaeuser, Veselin Grozdanov, Anna Speidel, Lisa Zondler, Wolfgang P. Ruf, Hanna Bayer, Martin Kiechle, Marisa S. Feiler, Axel Freischmidt, David Brenner, Anke Witting, Bastian Hengerer, Marcus Fändrich, Albert C. Ludolph, Jochen H. Weishaupt, Frank Gillardon & Karin M. Danzer. (2015) Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes. Acta Neuropathologica 131:3, pages 379-391.
Crossref
Crossref
Tessandra Stewart, Vesna Sossi, Jan O Aasly, Zbigniew K Wszolek, Ryan J Uitti, Kazuko Hasegawa, Teruo Yokoyama, Cyrus P Zabetian, James B Leverenz, Alexander Jon Stoessl, Yu Wang, Carmen Ginghina, Changqin Liu, Kevin C Cain, Peggy Auinger, Un Jung Kang, Poul Henning Jensen, Min Shi & Jing Zhang. (2015) Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity. Acta Neuropathologica Communications 3:1.
Crossref
Crossref
Niklas K. U. Koehler, Elke Stransky, Mirjam Meyer, Susanne Gaertner, Mona Shing, Martina Schnaidt, Maria S. Celej, Thomas M. Jovin, Thomas Leyhe, Christoph Laske, Anil Batra, Gerhard Buchkremer, Andreas J. Fallgatter, Dorothee Wernet & Elke Richartz-Salzburger. (2015) Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging. PLOS ONE 10:4, pages e0123444.
Crossref
Crossref
Joseph Dale CombsChengshan Wang. 2015. Recent Progress in Colloid and Surface Chemistry with Biological Applications. Recent Progress in Colloid and Surface Chemistry with Biological Applications
89
108
.
S.N. Pchelina, E.P. Nuzhnyi, A.K. Emelyanov, T.M. Boukina, T.S. Usenko, M.A. Nikolaev, G.N. Salogub, A.F. Yakimovskii & E. Yu. Zakharova. (2014) Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases. Neuroscience Letters 583, pages 188-193.
Crossref
Crossref
M.-B. Fares, N. Ait-Bouziad, I. Dikiy, M. K. Mbefo, A. Jovi i , A. Kiely, J. L. Holton, S.-J. Lee, A. D. Gitler, D. Eliezer & H. A. Lashuel. (2014) The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of -synuclein, and enhances its secretion and nuclear localization in cells. Human Molecular Genetics 23:17, pages 4491-4509.
Crossref
Crossref
Christine Lund Kragh, Marina Romero-Ramos, Glenda Halliday & Poul Henning Jensen. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
691
726
.
Jon B Toledo, Nigel J Cairns, Xiao Da, Kewei Chen, Deborah Carter, Adam Fleisher, Erin Householder, Napatkamon Ayutyanont, Auttawut Roontiva, Robert J Bauer, Paul Eisen, Leslie M Shaw, Christos Davatzikos, Michael W Weiner, Eric M Reiman, John C Morris & John Q Trojanowski. (2013) Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathologica Communications 1:1.
Crossref
Crossref
Jon B. Toledo, Ane Korff, Leslie M. Shaw, John Q. Trojanowski & Jing Zhang. (2013) CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease. Acta Neuropathologica 126:5, pages 683-697.
Crossref
Crossref
Daniela Besong-AgboElias WolfFrank JessenMatthias OechsnerEva HametnerWerner PoeweMarkus ReindlWolfgang H. OertelCarmen NoelkerMichael BacherRichard Dodel. (2013) Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease. Neurology 80:2, pages 169-175.
Crossref
Crossref
Binbin Zhou, Yuanqiang Hao, Chengshan Wang, Ding Li, You-Nian Liu & Feimeng Zhou. (2013) Conversion of natively unstructured α-synuclein to its α-helical conformation significantly attenuates production of reactive oxygen species. Journal of Inorganic Biochemistry 118, pages 68-73.
Crossref
Crossref
Gil Rosenman & Nadav Amdursky. 2012. One‐Dimensional Nanostructures. One‐Dimensional Nanostructures
207
236
.
Elizabeta B. Mukaetova-Ladinska, Zeinab Abdel-All, Steven Dodds, Joana Andrade, Joaquim Alves da Silva, Raj N. Kalaria & John T. O'Brien. (2012) Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study. Age and Ageing 41:3, pages 408-412.
Crossref
Crossref
Nadav Amdursky, Ehud Gazit & Gil Rosenman. (2012) Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process. Biochemical and Biophysical Research Communications 419:2, pages 232-237.
Crossref
Crossref
Michael Eller & David R. Williams. (2011) α-Synuclein in Parkinson disease and other neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine 49:3.
Crossref
Crossref
Yarui An, Linlin Tang, Xiaoli Jiang, Hua Chen, Meicheng Yang, Litong Jin, Shengping Zhang, Chuangui Wang & Wen Zhang. (2010) A Photoelectrochemical Immunosensor Based on Au-Doped TiO2 Nanotube Arrays for the Detection of α-Synuclein. Chemistry - A European Journal 16:48, pages 14439-14446.
Crossref
Crossref
Brit Mollenhauer, Omar MA El-Agnaf, Katrin Marcus, Claudia Trenkwalder & Michael G Schlossmacher. (2010) Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies. Biomarkers in Medicine 4:5, pages 683-699.
Crossref
Crossref
R.B. Tinsley, K. Kotschet, D. Modesto, H. Ng, Y. Wang, P. Nagley, G. Shaw & M.K. Horne. (2010) Sensitive and specific detection of α‐synuclein in human plasma. Journal of Neuroscience Research 88:12, pages 2693-2700.
Crossref
Crossref
Min Shi, Cyrus P. Zabetian, Aneeka M. Hancock, Carmen Ginghina, Zhen Hong, Dora Yearout, Kathryn A. Chung, Joseph F. Quinn, Elaine R. Peskind, Douglas Galasko, Joseph Jankovic, James B. Leverenz & Jing Zhang. (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neuroscience Letters 480:1, pages 78-82.
Crossref
Crossref
Min Shi, Bertrand R. Huber & Jing Zhang. (2010) Biomarkers for Cognitive Impairment in Parkinson Disease. Brain Pathology 20:3, pages 660-671.
Crossref
Crossref
Neal R. Cutler, John J. Sramek, Michael F. Murphy, Henry RiordanSrSr, Peter Bieck & Angelico Carta. 2010. Critical Pathways to Success in CNS Drug Development. Critical Pathways to Success in CNS Drug Development
101
166
.
Raquel Duran, Francisco J. Barrero, Blas Morales, Juan D. Luna, Manuel Ramirez & Francisco Vives. (2010) Plasma α-synuclein in patients with Parkinson's disease with and without treatment. Movement Disorders 25:4, pages 489-493.
Crossref
Crossref
Zhen Hong, Min Shi, Kathryn A. Chung, Joseph F. Quinn, Elaine R. Peskind, Douglas Galasko, Joseph Jankovic, Cyrus P. Zabetian, James B. Leverenz, Geoffrey Baird, Thomas J. Montine, Aneeka M. Hancock, Hyejin Hwang, Catherine Pan, Joshua Bradner, Un J. Kang, Poul H. Jensen & Jing Zhang. (2010) DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease. Brain 133:3, pages 713-726.
Crossref
Crossref
Chengshan Wang, Nilam Shah, Garima Thakur, Feimeng Zhou & Roger M. Leblanc. (2010) α-Synuclein in α-helical conformation at air–water interface: implication of conformation and orientation changes during its accumulation/aggregation. Chemical Communications 46:36, pages 6702.
Crossref
Crossref
Gráinne C. O’Keeffe, Andrew W. Michell & Roger A. Barker. (2009) Biomarkers in Huntington's and Parkinson's Disease. Annals of the New York Academy of Sciences 1180:1, pages 97-110.
Crossref
Crossref
Brit Mollenhauer & Claudia Trenkwalder. (2009) Neurochemical biomarkers in the differential diagnosis of movement disorders. Movement Disorders 24:10, pages 1411-1426.
Crossref
Crossref
Brit Mollenhauer, Valerie Cullen, Ilana Kahn, Bryan Krastins, Tiago F. Outeiro, Imelda Pepivani, Juliana Ng, Walter Schulz-Schaeffer, Hans A. Kretzschmar, Pamela J. McLean, Claudia Trenkwalder, David A. Sarracino, Jean-Paul VonSattel, Joseph J. Locascio, Omar M.A. El-Agnaf & Michael G. Schlossmacher. (2008) Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Experimental Neurology 213:2, pages 315-325.
Crossref
Crossref
Deborah C. Mash, Nikhil Adi, Linda Duque, John Pablo, Mahendra Kumar & Frank R. Ervin. (2008) Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and Alcohol Dependence 94:1-3, pages 246-250.
Crossref
Crossref
Ashley D. Reynolds, Jason G. Glanzer, Irena Kadiu, Mary Ricardo-Dukelow, Anathbandhu Chaudhuri, Pawel Ciborowski, Ronald Cerny, Benjamin Gelman, Mark P. Thomas, R. Lee Mosley & Howard E. Gendelman. (2008) Nitrated alpha-synuclein-activated microglial profiling for Parkinson’s disease. Journal of Neurochemistry 104:6, pages 1504-1525.
Crossref
Crossref
Wieneke J.A. van Geel, W. Farid Abdo, René Melis, Sonja Williams, Bastiaan R. Bloem & Marcel M. Verbeek. (2008) A more efficient enzyme-linked immunosorbent assay for measurement of α-synuclein in cerebrospinal fluid. Journal of Neuroscience Methods 168:1, pages 182-185.
Crossref
Crossref
Brit Mollenhauer & Michael G. Schlossmacher. 2008. Parkinson's Disease. Parkinson's Disease
559
573
.